Agios Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $937.1M
Liabilities Breakdown FY2023
Total Liabilities: $126.1M
Asset Breakdown
Total Assets: $937.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $88.2M | 9.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $19.1M | 2.0% |
| Property, Plant & Equipment | $15.4M | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $814.5M | 86.9% |
Liabilities Breakdown
Total Liabilities: $126.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.8M | 7.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $116.3M | 92.2% |